
News from openpr.com
Media Bias Ratings
Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top openpr.com News

United States · United StatesNovartis successfully completed the acquisition of the US biotech company Regulus Therapeutics. As the Group announced on Wednesday, it was offered 74.49 percent of the outstanding shares at the end of the offer period that has now expired.See the Story